Breast Cancer: Radiation Therapy with the Oral Drug Olaparib
Research Question:
How well does radiation therapy with or without olaparib work in treating patients
with inflammatory breast cancer?
Basic Study Information
Purpose:
This phase II trial studies how well radiation therapy with or without olaparib works
in treating patients with inflammatory breast cancer. Radiation therapy uses high
energy x-rays to kill tumor cells and shrink tumors. Olaparib may stop the growth
of tumor cells by blocking some of the enzymes needed for cell growth. It is not yet
known whether radiation therapy with or without olaparib may work better in treating
patients with inflammatory breast cancer.
Location: University of Rochester Medical Center
Study Reference #: CBRS18119
Lead Researcher (Principal Investigator)
Lead Researcher:
Ajay Dhakal
Study Contact Information
Study Coordinator: Laura Mitchell
Phone: (585) 275-7763
Email: Laura_Mitchell@URMC.Rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search